fbpx
May 3, 2024

New cancer clinical trial: Talimogene Laherparepvec, Capecitabine, and Chemoradiation Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

Published on: October 03, 2017 at 10:00AM
Conditions:   Rectal Adenocarcinoma;   Stage III Rectal Cancer AJCC v7;   Stage IIIA Rectal Cancer AJCC v7;   Stage IIIB Rectal Cancer AJCC v7;   Stage IIIC Rectal Cancer AJCC v7;   Stage IV Rectal Cancer AJCC v7;   Stage IVA Rectal Cancer AJCC v7;   Stage IVB Rectal Cancer AJCC v7
Interventions:   Drug: Capecitabine;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Oxaliplatin;   Radiation: Radiation Therapy;   Biological: Talimogene Laherparepvec
Sponsor:   National Cancer Institute (NCI)
Recruiting
http://ift.tt/2wwAhV0

%d bloggers like this: